Tweet
Oseltamivir, commonly known as Tamiflu, stands as a potent weapon against influenza viruses. As a neuraminidase inhibitor, it curtails viral replication by hindering the release of newly formed viruses from infected cells, thereby mitigating the severity and duration of flu symptoms. Its efficacy spans various influenza strains, including H1N1 and H3N2, making it a versatile tool in combating seasonal outbreaks and pandemics. Administered orally, Oseltamivir 75 mg capsules offers convenience and ease of use, particularly beneficial in managing widespread infections. Despite debates surrounding its efficacy and potential side effects, extensive clinical trials and real-world applications have substantiated its role in reducing hospitalisations and complications associated with influenza. Timely administration, typically within 48 hours of symptom onset, maximises its effectiveness. As part of comprehensive influenza management, Oseltamivir remains a cornerstone therapy, offering relief to individuals afflicted by the flu while contributing to public health containment efforts.
Homepage: Genericcures
Homepage: Genericcures